U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492121) titled 'Screening for Brain Metastases' on Sept. 25, 2025.
Brief Summary: The survival of patients with CNS metastases often remains limited to some months. CNS metastases are also associated with neurological decline and decrease of quality of life. An early identification of CNS metastases may potentially lead to more therapeutic options and prevent or delay the development of neurological symptoms and signs. Patients with cancer associated with a high risk of developing CNS metastasis will be enrolled in this trial. These patients are candidates for a screening brain MRI program in the routine management as recommended in current guidel...